Urinary tract infections: epidemiology, mechanisms of infection and treatment options (original) (raw)

• Stamm, W. E. & Norrby, S. R. Urinary tract infections: disease panorama and challenges. J. Infect. Dis. 183 (Suppl. 1), S1–S4 (2001).
  PubMed Google Scholar
• Schappert, S. M. & Rechtsteiner, E. A. Ambulatory medical care utilization estimates for 2007. Vital Health Stat. 13, 1–38 (2011).
  Google Scholar
• Foxman, B. Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden. Infect. Dis. Clin. North Am. 28, 1–13 (2014). This paper presents the most recent information about UTIs and their socioeconomic impact.
  PubMed Google Scholar
• Foxman, B. The epidemiology of urinary tract infection. Nature Rev. Urol. 7, 653–660 (2010).
  Google Scholar
• Hooton, T. M. Uncomplicated urinary tract infection. New Engl. J. Med. 366, 1028–1037 (2012).
  CAS PubMed Google Scholar
• Nielubowicz, G. R. & Mobley, H. L. Host–pathogen interactions in urinary tract infection. Nature Rev. Urol. 7, 430–441 (2010). This review compares the strategies used by two important uropathogens, E. coli and P. mirabilis , the host response to each pathogen, and the current treatments and therapies to prevent UTIs.
  CAS Google Scholar
• Hannan, T. J. et al. Host–pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection. FEMS Microbiol. Rev. 36, 616–648 (2012).
  CAS PubMed PubMed Central Google Scholar
• Lichtenberger, P. & Hooton, T. M. Complicated urinary tract infections. Curr. Infect. Dis. Rep. 10, 499–504 (2008).
  PubMed Google Scholar
• Levison, M. E. & Kaye, D. Treatment of complicated urinary tract infections with an emphasis on drug-resistant Gram-negative uropathogens. Curr. Infect. Dis. Rep. 15, 109–115 (2013).
  PubMed Google Scholar
• Lo, E. et al. Strategies to prevent catheter-associated urinary tract infections in acute care hospitals: 2014 update. Infect. Control Hosp. Epidemiol. 35, 464–479 (2014).
  PubMed Google Scholar
• Chenoweth, C. E., Gould, C. V. & Saint, S. Diagnosis, management, and prevention of catheter-associated urinary tract infections. Infect. Dis. Clin. North Am. 28, 105–119 (2014).
  PubMed Google Scholar
• Kline, K. A., Schwartz, D. J., Lewis, W. G., Hultgren, S. J. & Lewis, A. L. Immune activation and suppression by group B Streptococcus in a murine model of urinary tract infection. Infect. Immun. 79, 3588–3595 (2011).
  CAS PubMed PubMed Central Google Scholar
• Ronald, A. The etiology of urinary tract infection: traditional and emerging pathogens. Am. J. Med. 113 (Suppl. 1A), 14S–19S (2002).
  PubMed Google Scholar
• Fisher, J. F., Kavanagh, K., Sobel, J. D., Kauffman, C. A. & Newman, C. A. Candida urinary tract infection: pathogenesis. Clin. Infect. Dis. 52 (Suppl. 6), S437–S451 (2011).
  PubMed Google Scholar
• Chen, Y. H., Ko, W. C. & Hsueh, P. R. Emerging resistance problems and future perspectives in pharmacotherapy for complicated urinary tract infections. Expert Opin. Pharmacother. 14, 587–596 (2013). This paper highlights the emerging resistance among bacterial pathogens, the problems we face in combating these resistant bacteria and potential effective agents for the treatment of UTIs caused by multidrug-resistant pathogens.
  PubMed Google Scholar
• Jacobsen, S. M., Stickler, D. J., Mobley, H. L. & Shirtliff, M. E. Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis. Clin. Microbiol. Rev. 21, 26–59 (2008).
  CAS PubMed PubMed Central Google Scholar
• Kostakioti, M., Hultgren, S. J. & Hadjifrangiskou, M. Molecular blueprint of uropathogenic Escherichia coli virulence provides clues toward the development of anti-virulence therapeutics. Virulence 3, 592–594 (2012).
  PubMed PubMed Central Google Scholar
• Subashchandranose, S. et al. Host-specific induction of Escherichia coli fitness genes during human urinary tract infection. Proc. Natl Acad. Sci. USA 111, 18327–18332 (2014).
  Google Scholar
• Khandelwal, P., Abraham, S. N. & Apodaca, G. Cell biology and physiology of the uroepithelium. Am. J. Physiol. Renal Physiol. 297, F1477–F1501 (2009).
  CAS PubMed PubMed Central Google Scholar
• Lee, G. Uroplakins in the lower urinary tract. Int. Neurourol. J. 15, 4–12 (2011).
  PubMed PubMed Central Google Scholar
• Eto, D. S., Jones, T. A., Sundsbak, J. L. & Mulvey, M. A. Integrin-mediated host cell invasion by type 1-piliated uropathogenic Escherichia coli. PLoS Pathog. 3, e100 (2007).
  PubMed PubMed Central Google Scholar
• Niveditha, S., Pramodhini, S., Umadevi, S., Kumar, S. & Stephen, S. The isolation and the biofilm formation of uropathogens in the patients with catheter associated urinary tract infections (UTIs). J. Clin. Diagn. Res. 6, 1478–1482 (2012).
  CAS PubMed PubMed Central Google Scholar
• Jacobsen, S. M. & Shirtliff, M. E. Proteus mirabilis biofilms and catheter-associated urinary tract infections. Virulence 2, 460–465 (2011). This paper briefly outlines the steps of P. mirabilis crystalline-biofilm formation during CAUTIs.
  PubMed Google Scholar
• Kline, K. A., Dodson, K. W., Caparon, M. G. & Hultgren, S. J. A tale of two pili: assembly and function of pili in bacteria. Trends Microbiol. 18, 224–232 (2010).
  CAS PubMed PubMed Central Google Scholar
• Wurpel, D. J., Beatson, S. A., Totsika, M., Petty, N. K. & Schembri, M. A. Chaperone–usher fimbriae of Escherichia coli. PLoS ONE 8, e52835 (2013).
  CAS PubMed PubMed Central Google Scholar
• Waksman, G. & Hultgren, S. J. Structural biology of the chaperone–usher pathway of pilus biogenesis. Nature Rev. Microbiol. 7, 765–774 (2009). This review presents the most current, in-depth understanding of how pili are assembled through the chaperone–usher pathway.
  CAS Google Scholar
• Vallet, I., Olson, J. W., Lory, S., Lazdunski, A. & Filloux, A. The chaperone/usher pathways of Pseudomonas aeruginosa: identification of fimbrial gene clusters (cup) and their involvement in biofilm formation. Proc. Natl Acad. Sci. USA 98, 6911–6916 (2001).
  CAS PubMed Google Scholar
• Chorell, E. et al. Mapping pilicide anti-virulence effect in Escherichia coli, a comprehensive structure-activity study. Bioorg. Med. Chem. 20, 3128–3142 (2012).
  CAS PubMed PubMed Central Google Scholar
• Thanassi, D. G., Saulino, E. T. & Hultgren, S. J. The chaperone/usher pathway: a major terminal branch of the general secretory pathway. Curr. Opin. Microbiol. 1, 223–231 (1998).
  CAS PubMed Google Scholar
• Piatek, R. et al. Pilicides inhibit the FGL chaperone/usher assisted biogenesis of the Dr fimbrial polyadhesin from uropathogenic Escherichia coli. BMC Microbiol. 13, 131 (2013). This paper provides a brief overview of two similar CUP pilus assembly pathways and shows that antivirulence compounds (pilicides) which were originally designed to specifically target one pathway have broad-spectrum activity against both CUP pilus pathways in E. coli.
  CAS PubMed PubMed Central Google Scholar
• Dang, H. T. et al. Syntheses and biological evaluation of 2-amino-3-acyl-tetrahydrobenzothiophene derivatives; antibacterial agents with antivirulence activity. Org. Biomol. Chem. 12, 1942–1956 (2014).
  PubMed PubMed Central Google Scholar
• Geibel, S., Procko, E., Hultgren, S. J., Baker, D. & Waksman, G. Structural and energetic basis of folded-protein transport by the FimD usher. Nature 496, 243–246 (2013).
  CAS PubMed PubMed Central Google Scholar
• Wright, K. J. & Hultgren, S. J. Sticky fibers and uropathogenesis: bacterial adhesins in the urinary tract. Future Microbiol. 1, 75–87 (2006).
  CAS PubMed Google Scholar
• Hadjifrangiskou, M. et al. Transposon mutagenesis identifies uropathogenic Escherichia coli biofilm factors. J. Bacteriol. 194, 6195–6205 (2012).
  CAS PubMed PubMed Central Google Scholar
• Guiton, P. S. et al. Combinatorial small-molecule therapy prevents uropathogenic Escherichia coli catheter-associated urinary tract infections in mice. Antimicrob. Agents Chemother. 56, 4738–4745 (2012).
  CAS PubMed PubMed Central Google Scholar
• Martinez, J. J. & Hultgren, S. J. Requirement of Rho-family GTPases in the invasion of type 1-piliated uropathogenic Escherichia coli. Cell. Microbiol. 4, 19–28 (2002).
  CAS PubMed Google Scholar
• Song, J. et al. TLR4-mediated expulsion of bacteria from infected bladder epithelial cells. Proc. Natl Acad. Sci. USA 106, 14966–14971 (2009).
  CAS PubMed Google Scholar
• Anderson, G. G. et al. Intracellular bacterial biofilm-like pods in urinary tract infections. Science 301, 105–107 (2003). This is the first paper to describe the intracellular cycle of a uropathogen and its importance for persistance.
  CAS PubMed Google Scholar
• Hannan, T. J., Mysorekar, I. U., Hung, C. S., Isaacson-Schmid, M. L. & Hultgren, S. J. Early severe inflammatory responses to uropathogenic E. coli predispose to chronic and recurrent urinary tract infection. PLoS Pathog. 6, e1001042 (2010).
  PubMed PubMed Central Google Scholar
• Kostakioti, M., Hadjifrangiskou, M. & Hultgren, S. J. Bacterial biofilms: development, dispersal, and therapeutic strategies in the dawn of the postantibiotic era. Cold Spring Harb. Perspect. Med. 3, a010306 (2013). This review details the importance of biofilm formation for the survival and persistance of different pathogens and the threat that represents in clinical settings. In addition, it discusses novel alternative strategies for the prevention of biofilm formation.
  PubMed PubMed Central Google Scholar
• Rosen, D. A., Hooton, T. M., Stamm, W. E., Humphrey, P. A. & Hultgren, S. J. Detection of intracellular bacterial communities in human urinary tract infection. PLoS Med. 4, e329 (2007).
  PubMed PubMed Central Google Scholar
• Robino, L. et al. Intracellular bacteria in the pathogenesis of Escherichia coli urinary tract infection in children. Clin. Infect. Dis. 59, e158–e164 (2014).
  CAS PubMed PubMed Central Google Scholar
• Schwartz, D. J., Chen, S. L., Hultgren, S. J. & Seed, P. C. Population dynamics and niche distribution of uropathogenic Escherichia coli during acute and chronic urinary tract infection. Infect. Immun. 79, 4250–4259 (2011).
  CAS PubMed PubMed Central Google Scholar
• Blango, M. G., Ott, E. M., Erman, A., Veranic, P. & Mulvey, M. A. Forced resurgence and targeting of intracellular uropathogenic Escherichia coli reservoirs. PLoS ONE 9, e93327 (2014).
  PubMed PubMed Central Google Scholar
• Rice, J. C. et al. Pyelonephritic Escherichia coli expressing P fimbriae decrease immune response of the mouse kidney. J. Am. Soc. Nephrol. 16, 3583–3591 (2005).
  CAS PubMed Google Scholar
• Ashkar, A. A., Mossman, K. L., Coombes, B. K., Gyles, C. L. & Mackenzie, R. FimH adhesin of type 1 fimbriae is a potent inducer of innate antimicrobial responses which requires TLR4 and type 1 interferon signalling. PLoS Pathog. 4, e1000233 (2008).
  PubMed PubMed Central Google Scholar
• Gerlach, G. F., Clegg, S. & Allen, B. L. Identification and characterization of the genes encoding the type-3 and type-1 fimbrial adhesins of Klebsiella pneumoniae. J. Bacteriol. 171, 1262–1270 (1989).
  CAS PubMed PubMed Central Google Scholar
• Stahlhut, S. G. et al. Comparative structure–function analysis of mannose-specific FimH adhesins from Klebsiella pneumoniae and Escherichia coli. J. Bacteriol. 191, 6592–6601 (2009).
  CAS PubMed PubMed Central Google Scholar
• Rosen, D. A. et al. Molecular variations in Klebsiella pneumoniae and Escherichia coli FimH affect function and pathogenesis in the urinary tract. Infect. Immun. 76, 3346–3356 (2008).
  CAS PubMed PubMed Central Google Scholar
• Rosen, D. A. et al. Utilization of an intracellular bacterial community pathway in Klebsiella pneumoniae urinary tract infection and the effects of FimK on type 1 pilus expression. Infect. Immun. 76, 3337–3345 (2008).
  CAS PubMed PubMed Central Google Scholar
• Murphy, C. N., Mortensen, M. S., Krogfelt, K. A. & Clegg, S. Role of Klebsiella pneumoniae type 1 and type 3 fimbriae in colonizing silicone tubes implanted into the bladders of mice as a model of catheter-associated urinary tract infections. Infect. Immun. 81, 3009–3017 (2013).
  CAS PubMed PubMed Central Google Scholar
• Struve, C., Bojer, M. & Krogfelt, K. A. Characterization of Klebsiella pneumoniae type 1 fimbriae by detection of phase variation during colonization and infection and impact on virulence. Infect. Immun. 76, 4055–4065 (2008).
  CAS PubMed PubMed Central Google Scholar
• Armbruster, C. E. & Mobley, H. L. Merging mythology and morphology: the multifaceted lifestyle of Proteus mirabilis. Nature Rev. Microbiol. 10, 743–754 (2012).
  CAS Google Scholar
• Arias, C. A. & Murray, B. E. The rise of the Enterococcus: beyond vancomycin resistance. Nature Rev. Microbiol. 10, 266–278 (2012). This is a comprehensive review of the epidemiology, pathogenesis and mechanism of antimicrobial resistance of Enterococcus spp. This review also outlines how Enterococcus spp. are becoming a challenging nosocomial problem.
  CAS Google Scholar
• Guiton, P. S., Hung, C. S., Hancock, L. E., Caparon, M. G. & Hultgren, S. J. Enterococcal biofilm formation and virulence in an optimized murine model of foreign body-associated urinary tract infections. Infect. Immun. 78, 4166–4175 (2010).
  CAS PubMed PubMed Central Google Scholar
• Nielsen, H. V. et al. The metal ion-dependent adhesion site motif of the Enterococcus faecalis EbpA pilin mediates pilus function in catheter-associated urinary tract infection. mBio 3, e00177-12 (2012).
  PubMed PubMed Central Google Scholar
• Goble, N. M., Clarke, T. & Hammonds, J. C. Histological changes in the urinary bladder secondary to urethral catheterisation. Br. J. Urol. 63, 354–357 (1989).
  CAS PubMed Google Scholar
• Glahn, B. E. Influence of drainage conditions on mucosal bladder damage by indwelling catheters. I. Pressure study. Scand. J. Urol. Nephrol. 22, 87–92 (1988).
  CAS PubMed Google Scholar
• Guiton, P. S., Hannan, T. J., Ford, B., Caparon, M. G. & Hultgren, S. J. Enterococcus faecalis overcomes foreign body-mediated inflammation to establish urinary tract infections. Infect. Immun. 81, 329–339 (2013).
  CAS PubMed PubMed Central Google Scholar
• Flores-Mireles, A. L., Pinkner, J. S., Caparon, M. G. & Hultgren, S. J. EbpA vaccine antibodies block binding of Enterococcus faecalis to fibrinogen to prevent catheter-associated bladder infection in mice. Sci. Transl. Med. 6, 254ra127 (2014). This is the first study to dissect the mechanism of E. faecalis infection during a CAUTI; this work led to the development of a vaccine that prevents infection in a mouse model of a CAUTI.
  PubMed PubMed Central Google Scholar
• Nielsen, H. V. et al. Pilin and sortase residues critical for endocarditis- and biofilm-associated pilus biogenesis in Enterococcus faecalis. J. Bacteriol. 195, 4484–4495 (2013).
  CAS PubMed PubMed Central Google Scholar
• Dhakal, B. K. & Mulvey, M. A. The UPEC pore-forming toxin α-hemolysin triggers proteolysis of host proteins to disrupt cell adhesion, inflammatory, and survival pathways. Cell Host Microbe 11, 58–69 (2012).
  CAS PubMed PubMed Central Google Scholar
• Nagamatsu, K. et al. Dysregulation of Escherichia coli α-hemolysin expression alters the course of acute and persistent urinary tract infection. Proc. Natl Acad. Sci. USA 112, E871–E880 (2015).
  CAS PubMed Google Scholar
• Mulvey, M. A. et al. Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli. Science 282, 1494–1497 (1998).
  CAS PubMed Google Scholar
• Justice, S. S. & Hunstad, D. A. UPEC hemolysin: more than just for making holes. Cell Host Microbe 11, 4–5 (2012).
  CAS PubMed PubMed Central Google Scholar
• Hannan, T. J. et al. LeuX tRNA-dependent and -independent mechanisms of Escherichia coli pathogenesis in acute cystitis. Mol. Microbiol. 67, 116–128 (2008).
  CAS PubMed Google Scholar
• Garcia, T. A., Ventura, C. L., Smith, M. A., Merrell, D. S. & O'Brien, A. D. Cytotoxic necrotizing factor 1 and hemolysin from uropathogenic Escherichia coli elicit different host responses in the murine bladder. Infect. Immun. 81, 99–109 (2013).
  CAS PubMed PubMed Central Google Scholar
• Landraud, L. et al. E. coli CNF1 toxin: a two-in-one system for host-cell invasion. Int. J. Med. Microbiol. 293, 513–518 (2004).
  CAS PubMed Google Scholar
• Piteau, M. et al. Lu/BCAM adhesion glycoprotein is a receptor for Escherichia coli cytotoxic necrotizing factor 1 (CNF1). PLoS Pathog. 10, e1003884 (2014).
  PubMed PubMed Central Google Scholar
• Doye, A. et al. CNF1 exploits the ubiquitin-proteasome machinery to restrict Rho GTPase activation for bacterial host cell invasion. Cell 111, 553–564 (2002).
  CAS PubMed Google Scholar
• Miraglia, A. G. et al. Cytotoxic necrotizing factor 1 prevents apoptosis via the Akt/IκB kinase pathway: role of nuclear factor-κB and Bcl-2. Mol. Biol. Cell 18, 2735–2744 (2007).
  CAS PubMed PubMed Central Google Scholar
• Cestari, S. E. et al. Molecular detection of HpmA and HlyA hemolysin of uropathogenic Proteus mirabilis. Curr. Microbiol. 67, 703–707 (2013).
  CAS PubMed Google Scholar
• Alamuri, P. & Mobley, H. L. A novel autotransporter of uropathogenic Proteus mirabilis is both a cytotoxin and an agglutinin. Mol. Microbiol. 68, 997–1017 (2008).
  CAS PubMed Google Scholar
• Mittal, R., Khandwaha, R. K., Gupta, V., Mittal, P. K. & Harjai, K. Phenotypic characters of urinary isolates of Pseudomonas aeruginosa and their association with mouse renal colonization. Indian J. Med. Res. 123, 67–72 (2006).
  PubMed Google Scholar
• Mittal, R., Sharma, S., Chhibber, S. & Harjai, K. Iron dictates the virulence of Pseudomonas aeruginosa in urinary tract infections. J. Biomed. Sci. 15, 731–741 (2008).
  PubMed Google Scholar
• Rocha, C. L., Coburn, J., Rucks, E. A. & Olson, J. C. Characterization of Pseudomonas aeruginosa exoenzyme S as a bifunctional enzyme in J774A.1 macrophages. Infect. Immun. 71, 5296–5305 (2003).
  CAS PubMed PubMed Central Google Scholar
• Cathcart, G. R. et al. Novel inhibitors of the Pseudomonas aeruginosa virulence factor LasB: a potential therapeutic approach for the attenuation of virulence mechanisms in pseudomonal infection. Antimicrob. Agents Chemother. 55, 2670–2678 (2011).
  CAS PubMed PubMed Central Google Scholar
• Meyers, D. J. et al. In vivo and in vitro toxicity of phospholipase C from Pseudomonas aeruginosa. Toxicon 30, 161–169 (1992).
  CAS PubMed Google Scholar
• Wargo, M. J. et al. Hemolytic phospholipase C inhibition protects lung function during Pseudomonas aeruginosa infection. Am. J. Respir. Crit. Care Med. 184, 345–354 (2011).
  CAS PubMed PubMed Central Google Scholar
• Berka, R. M. & Vasil, M. L. Phospholipase C (heat-labile hemolysin) of Pseudomonas aeruginosa: purification and preliminary characterization. J. Bacteriol. 152, 239–245 (1982).
  CAS PubMed PubMed Central Google Scholar
• Senturk, S., Ulusoy, S., Bosgelmez-Tinaz, G. & Yagci, A. Quorum sensing and virulence of Pseudomonas aeruginosa during urinary tract infections. J. Infect. Dev. Ctries 6, 501–507 (2012).
  CAS PubMed Google Scholar
• Mittal, R., Aggarwal, S., Sharma, S., Chhibber, S. & Harjai, K. Urinary tract infections caused by Pseudomonas aeruginosa: a mini review. J. Infect. Publ. Health 2, 101–111 (2009).
  Google Scholar
• Li, X. et al. Visualization of Proteus mirabilis within the matrix of urease-induced bladder stones during experimental urinary tract infection. Infect. Immun. 70, 389–394 (2002).
  CAS PubMed PubMed Central Google Scholar
• Gatermann, S., John, J. & Marre, R. Staphylococcus saprophyticus urease: characterization and contribution to uropathogenicity in unobstructed urinary tract infection of rats. Infect. Immun. 57, 110–116 (1989).
  CAS PubMed PubMed Central Google Scholar
• Podschun, R. & Ullmann, U. Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin. Microbiol. Rev. 11, 589–603 (1998).
  CAS PubMed PubMed Central Google Scholar
• Visca, P. et al. Virulence determinants in Pseudomonas aeruginosa strains from urinary tract infections. Epidemiol. Infect. 108, 323–336 (1992).
  CAS PubMed PubMed Central Google Scholar
• Griffith, D. P., Musher, D. M. & Itin, C. Urease. The primary cause of infection-induced urinary stones. Invest. Urol. 13, 346–350 (1976).
  CAS PubMed Google Scholar
• Coker, C., Poore, C. A., Li, X. & Mobley, H. L. Pathogenesis of Proteus mirabilis urinary tract infection. Microbes Infect. 2, 1497–1505 (2000).
  CAS PubMed Google Scholar
• Kosikowska, P. & Berlicki, L. Urease inhibitors as potential drugs for gastric and urinary tract infections: a patent review. Expert Opin. Ther. Pat. 21, 945–957 (2011).
  CAS PubMed Google Scholar
• Jones, B. D. & Mobley, H. L. Genetic and biochemical diversity of ureases of Proteus, Providencia, and Morganella species isolated from urinary tract infection. Infect. Immun. 55, 2198–2203 (1987).
  CAS PubMed PubMed Central Google Scholar
• Stickler, D. J. Clinical complications of urinary catheters caused by crystalline biofilms: something needs to be done. J. Intern. Med. 276, 120–129 (2014).
  CAS PubMed Google Scholar
• Caza, M. & Kronstad, J. W. Shared and distinct mechanisms of iron acquisition by bacterial and fungal pathogens of humans. Front. Cell. Infect. Microbiol. 3, 80 (2013).
  PubMed PubMed Central Google Scholar
• Garcia, E. C., Brumbaugh, A. R. & Mobley, H. L. Redundancy and specificity of Escherichia coli iron acquisition systems during urinary tract infection. Infect. Immun. 79, 1225–1235 (2011).
  CAS PubMed PubMed Central Google Scholar
• Watts, R. E. et al. Contribution of siderophore systems to growth and urinary tract colonization of asymptomatic bacteriuria Escherichia coli. Infect. Immun. 80, 333–344 (2012).
  CAS PubMed PubMed Central Google Scholar
• Valdebenito, M., Crumbliss, A. L., Winkelmann, G. & Hantke, K. Environmental factors influence the production of enterobactin, salmochelin, aerobactin, and yersiniabactin in Escherichia coli strain Nissle 1917. Int. J. Med. Microbiol. 296, 513–520 (2006).
  CAS PubMed Google Scholar
• Chaturvedi, K. S., Hung, C. S., Crowley, J. R., Stapleton, A. E. & Henderson, J. P. The siderophore yersiniabactin binds copper to protect pathogens during infection. Nature Chem. Biol. 8, 731–736 (2012).
  CAS Google Scholar
• Himpsl, S. D. et al. Proteobactin and a yersiniabactin-related siderophore mediate iron acquisition in Proteus mirabilis. Mol. Microbiol. 78, 138–157 (2010).
  CAS PubMed PubMed Central Google Scholar
• Brumbaugh, A. R., Smith, S. N. & Mobley, H. L. Immunization with the yersiniabactin receptor, FyuA, protects against pyelonephritis in a murine model of urinary tract infection. Infect. Immun. 81, 3309–3316 (2013). This investigation uses data from genomic, proteomic and metabolic screens to identify vaccine targets in E. coli ., all of which are involved in iron acquisition. Vaccination with several iron receptors during experimental UTIs in mice revealed that these factors were an effective target for the development of vaccines.
  CAS PubMed PubMed Central Google Scholar
• Paterson, D. L. Resistance in Gram-negative bacteria: Enterobacteriaceae. Am. J. Infect. Control 34, S20–S28 (2006).
  PubMed Google Scholar
• Garau, J. Other antimicrobials of interest in the era of extended-spectrum β-lactamases: fosfomycin, nitrofurantoin and tigecycline. Clin. Microbiol. Infect. 14, 198–202 (2008).
  CAS PubMed Google Scholar
• Pendleton, J. N., Gorman, S. P. & Gilmore, B. F. Clinical relevance of the ESKAPE pathogens. Expert Rev. Anti Infect. Ther. 11, 297–308 (2013).
  CAS PubMed Google Scholar
• Gupta, K. & Bhadelia, N. Management of urinary tract infections from multidrug-resistant organisms. Infect. Dis. Clin. North Am. 28, 49–59 (2014).
  PubMed Google Scholar
• Bradford, P. A. Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin. Microbiol. Rev. 14, 933–951 (2001).
  CAS PubMed PubMed Central Google Scholar
• Courvalin, P. Vancomycin resistance in Gram-positive cocci. Clin. Infect. Dis. 42 (Suppl. 1), S25–S34 (2006).
  CAS PubMed Google Scholar
• Zhanel, G. G. et al. Ceftazidime–avibactam: a novel cephalosporin/β-lactamase inhibitor combination. Drugs 73, 159–177 (2013).
  CAS PubMed Google Scholar
• Livermore, D. M. & Mushtaq, S. Activity of biapenem (RPX2003) combined with the boronate β-lactamase inhibitor RPX7009 against carbapenem-resistant Enterobacteriaceae. J. Antimicrob. Chemother. 68, 1825–1831 (2013).
  CAS PubMed Google Scholar
• Mushtaq, S., Woodford, N., Hope, R., Adkin, R. & Livermore, D. M. Activity of BAL30072 alone or combined with β-lactamase inhibitors or with meropenem against carbapenem-resistant Enterobacteriaceae and non-fermenters. J. Antimicrob. Chemother. 68, 1601–1608 (2013).
  CAS PubMed Google Scholar
• Asadi Karam, M. R., Oloomi, M., Mahdavi, M., Habibi, M. & Bouzari, S. Vaccination with recombinant FimH fused with flagellin enhances cellular and humoral immunity against urinary tract infection in mice. Vaccine 31, 1210–1216 (2013).
  CAS PubMed Google Scholar
• Langermann, S. et al. Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli. J. Infect. Dis. 181, 774–778 (2000).
  CAS PubMed Google Scholar
• Langermann, S. et al. Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination. Science 276, 607–611 (1997). This pivotal study shows that blocking the interaction between the bacterial adhesin and the host receptor through vaccination can prevent UTIs in mice.
  CAS PubMed Google Scholar
• Roberts, J. A. et al. Antibody responses and protection from pyelonephritis following vaccination with purified Escherichia coli PapDG protein. J. Urol. 171, 1682–1685 (2004).
  CAS PubMed PubMed Central Google Scholar
• Savar, N. S. et al. In silico and in vivo studies of truncated forms of flagellin (FliC) of enteroaggregative Escherichia coli fused to FimH from uropathogenic Escherichia coli as a vaccine candidate against urinary tract infections. J. Biotechnol. 175, 31–37 (2014).
  CAS PubMed Google Scholar
• Li, X. et al. Use of translational fusion of the MrpH fimbrial adhesin-binding domain with the cholera toxin A2 domain, coexpressed with the cholera toxin B subunit, as an intranasal vaccine to prevent experimental urinary tract infection by Proteus mirabilis. Infect. Immun. 72, 7306–7310 (2004).
  CAS PubMed PubMed Central Google Scholar
• Sivick, K. E. & Mobley, H. L. Waging war against uropathogenic Escherichia coli: winning back the urinary tract. Infect. Immun. 78, 568–585 (2010).
  CAS PubMed Google Scholar
• O'Hanley, P., Lalonde, G. & Ji, G. Alpha-hemolysin contributes to the pathogenicity of piliated digalactoside-binding Escherichia coli in the kidney: efficacy of an α-hemolysin vaccine in preventing renal injury in the BALB/c mouse model of pyelonephritis. Infect. Immun. 59, 1153–1161 (1991).
  CAS PubMed PubMed Central Google Scholar
• Alamuri, P., Eaton, K. A., Himpsl, S. D., Smith, S. N. & Mobley, H. L. Vaccination with proteus toxic agglutinin, a hemolysin-independent cytotoxin in vivo, protects against Proteus mirabilis urinary tract infection. Infect. Immun. 77, 632–641 (2009).
  CAS PubMed Google Scholar
• Alteri, C. J., Hagan, E. C., Sivick, K. E., Smith, S. N. & Mobley, H. L. Mucosal immunization with iron receptor antigens protects against urinary tract infection. PLoS Pathog. 5, e1000586 (2009).
  PubMed PubMed Central Google Scholar
• Nagaya, H., Satoh, H., Kubo, K. & Maki, Y. Possible mechanism for the inhibition of gastric (H+ + K+)-adenosine triphosphatase by the proton pump inhibitor AG-1749. J. Pharmacol. Exp. Ther. 248, 799–805 (1989).
  CAS PubMed Google Scholar
• Sjostrom, J. E., Kuhler, T. & Larsson, H. Basis for the selective antibacterial activity in vitro of proton pump inhibitors against Helicobacter spp. Antimicrob. Agents Chemother. 41, 1797–1801 (1997).
  CAS PubMed PubMed Central Google Scholar
• Pinkner, J. S. et al. Rationally designed small compounds inhibit pilus biogenesis in uropathogenic bacteria. Proc. Natl Acad. Sci. USA 103, 17897–17902 (2006).
  CAS PubMed Google Scholar
• Cusumano, C. K. et al. Treatment and prevention of urinary tract infection with orally active FimH inhibitors. Sci. Transl. Med. 3, 109ra115 (2011). This key work uses compounds designed to prevent the E. coli type 1 pilus adhesin from binding the host receptor and demonstrates that these compounds are effective at preventing UTIs in mice.
  PubMed PubMed Central Google Scholar
• Greene, S. E. et al. Pilicide ec240 disrupts virulence circuits in uropathogenic E. coli. mBio 5, e02038 (2014). This is the first paper to describe the role of pilicide in transcriptional and translational regulation in UPEC.
  CAS PubMed PubMed Central Google Scholar
• Abgottspon, D. et al. Development of an aggregation assay to screen FimH antagonists. J. Microbiol. Methods 82, 249–255 (2010).
  CAS PubMed Google Scholar
• Klein, T. et al. FimH antagonists for the oral treatment of urinary tract infections: from design and synthesis to in vitro and in vivo evaluation. J. Med. Chem. 53, 8627–8641 (2010).
  CAS PubMed Google Scholar
• Totsika, M. et al. A FimH inhibitor prevents acute bladder infection and treats chronic cystitis caused by multidrug-resistant uropathogenic Escherichia coli ST131. J. Infect. Dis. 208, 921–928 (2013).
  CAS PubMed PubMed Central Google Scholar
• Schwartz, D. J. et al. Positively selected FimH residues enhance virulence during urinary tract infection by altering FimH conformation. Proc. Natl Acad. Sci. USA 110, 15530–15537 (2013). This study identifies the role of key FimH residues in protein conformation and virulence.
  CAS PubMed Google Scholar
• Sokurenko, E. V., Chesnokova, V., Doyle, R. J. & Hasty, D. L. Diversity of the Escherichia coli type 1 fimbrial lectin. Differential binding to mannosides and uroepithelial cells. J. Biol. Chem. 272, 17880–17886 (1997).
  CAS PubMed Google Scholar
• Weissman, S. J. et al. Differential stability and trade-off effects of pathoadaptive mutations in the Escherichia coli FimH adhesin. Infect. Immun. 75, 3548–3555 (2007).
  CAS PubMed PubMed Central Google Scholar
• Justice, S. S., Hunstad, D. A., Cegelski, L. & Hultgren, S. J. Morphological plasticity as a bacterial survival strategy. Nature Rev. Microbiol. 6, 162–168 (2008).
  CAS Google Scholar
• Horvath, D. J. Jr et al. Morphological plasticity promotes resistance to phagocyte killing of uropathogenic Escherichia coli. Microbes Infect. 13, 426–437 (2011).
  CAS PubMed Google Scholar
• Danese, P. N., Pratt, L. A., Dove, S. L. & Kolter, R. The outer membrane protein, antigen 43, mediates cell-to-cell interactions within Escherichia coli biofilms. Mol. Microbiol. 37, 424–432 (2000).
  CAS PubMed Google Scholar
• Lane, M. C., Li, X., Pearson, M. M., Simms, A. N. & Mobley, H. L. Oxygen-limiting conditions enrich for fimbriate cells of uropathogenic Proteus mirabilis and Escherichia coli. J. Bacteriol. 191, 1382–1392 (2009).
  CAS PubMed Google Scholar
• Yu, H. et al. Elastase LasB of Pseudomonas aeruginosa promotes biofilm formation partly through rhamnolipid-mediated regulation. Can. J. Microbiol. 60, 227–235 (2014).
  CAS PubMed Google Scholar
• Diggle, S. P. et al. The galactophilic lectin, LecA, contributes to biofilm development in Pseudomonas aeruginosa. Environ. Microbiol. 8, 1095–1104 (2006).
  CAS PubMed Google Scholar
• Fazli, M. et al. Regulation of biofilm formation in Pseudomonas and Burkholderia species. Environ. Microbiol. 16, 1961–1981 (2014).
  CAS PubMed Google Scholar
• Wagner, V. E., Li, L. L., Isabella, V. M. & Iglewski, B. H. Analysis of the hierarchy of quorum-sensing regulation in Pseudomonas aeruginosa. Anal. Bioanal. Chem. 387, 469–479 (2007).
  CAS PubMed Google Scholar
• Kumar, R., Chhibber, S. & Harjai, K. Quorum sensing is necessary for the virulence of Pseudomonas aeruginosa during urinary tract infection. Kidney Int. 76, 286–292 (2009).
  CAS PubMed Google Scholar
• Justice, S. S., Hunstad, D. A., Seed, P. C. & Hultgren, S. J. Filamentation by Escherichia coli subverts innate defenses during urinary tract infection. Proc. Natl Acad. Sci. USA 103, 19884–19889 (2006).
  CAS PubMed Google Scholar
• Morgenstein, R. M. & Rather, P. N. Role of the Umo proteins and the Rcs phosphorelay in the swarming motility of the wild type and an O-antigen (waaL) mutant of Proteus mirabilis. J. Bacteriol. 194, 669–676 (2012).
  CAS PubMed PubMed Central Google Scholar
• Walther-Rasmussen, J. & Hoiby, N. Cefotaximases (CTX-M-ases), an expanding family of extended-spectrum β-lactamases. Can. J. Microbiol. 50, 137–165 (2004).
  CAS PubMed Google Scholar
• Schwan, W. R. Flagella allow uropathogenic Escherichia coli ascension into murine kidneys. Int. J. Med. Microbiol. 298, 441–447 (2008).
  CAS PubMed Google Scholar
• Ulett, G. C. et al. Functional analysis of antigen 43 in uropathogenic Escherichia coli reveals a role in long-term persistence in the urinary tract. Infect. Immun. 75, 3233–3244 (2007).
  CAS PubMed PubMed Central Google Scholar
• Tarkkanen, A. M. et al. Fimbriation, capsulation, and iron-scavenging systems of Klebsiella strains associated with human urinary tract infection. Infect. Immun. 60, 1187–1192 (1992).
  CAS PubMed PubMed Central Google Scholar
• Podschun, R., Sievers, D., Fischer, A. & Ullmann, U. Serotypes, hemagglutinins, siderophore synthesis, and serum resistance of Klebsiella isolates causing human urinary tract infections. J. Infect. Dis. 168, 1415–1421 (1993).
  CAS PubMed Google Scholar
• Dumanski, A. J., Hedelin, H., Edin-Liljegren, A., Beauchemin, D. & McLean, R. J. Unique ability of the Proteus mirabilis capsule to enhance mineral growth in infectious urinary calculi. Infect. Immun. 62, 2998–3003 (1994).
  CAS PubMed PubMed Central Google Scholar
• Cole, S. J., Records, A. R., Orr, M. W., Linden, S. B. & Lee, V. T. Catheter-associated urinary tract infection by Pseudomonas aeruginosa is mediated by exopolysaccharide-independent biofilms. Infect. Immun. 82, 2048–2058 (2014).
  PubMed PubMed Central Google Scholar
• Gupta, P., Gupta, R. K. & Harjai, K. Multiple virulence factors regulated by quorum sensing may help in establishment and colonisation of urinary tract by Pseudomonas aeruginosa during experimental urinary tract infection. Indian J. Med. Microbiol. 31, 29–33 (2013).
  CAS PubMed Google Scholar
• Hell, W., Meyer, H. G. W. & Gatermann, S. G. Cloning of aas, a gene encoding a Staphylococcus saprophyticus surface protein with adhesive and autolytic properties. Mol. Microbiol. 29, 871–881 (1998).
  CAS PubMed Google Scholar
• Kline, K. A. et al. Characterization of a novel murine model of Staphylococcus saprophyticus urinary tract infection reveals roles for Ssp and SdrI in virulence. Infect. Immun. 78, 1943–1951 (2010).
  CAS PubMed PubMed Central Google Scholar